Prevalence of Metabolic Syndrome and its Components in Patients with Controlled Graves’ Disease
DOI:
https://doi.org/10.2478/amb-2024-0003Keywords:
Graves’ disease, metabolic syndrome, obesity, arterial hypertension, hyperglycemia, dyslipidemiaAbstract
Our aim was to assess the prevalence of the metabolic syndrome (MetS) and its components in patients with controlled Graves’ disease (GD). Methods: This was a cross-sectional study involving 95 consecutive patients with GD referred to our tertiary care
inpatient clinical center meeting the following inclusion criteria: controlled hyperthyroidism, treatment with antithyroid drugs, untreated Graves’ orbitopathy (GO), if present. Patients’ anthropometric parameters were evaluated and laboratory tests were performed with measurement of fasting blood glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides,
thyroid hormone and antibody levels. The presence of the MetS and its components as defined by the International Diabetes Federation from 2009 were evaluated. Results: In our patient cohort 82.1% were females, 17.9% were males, mean age 50.2 ± 13 years, with median duration of GD 16.5 months. The MetS was observed in 32.6% of our patients, obesity – in 34.7%, hyperglycemia in 38.9%, arterial hypertension – in 36.8%, low HDL-cholesterol – in 23.2% and hypertriglyceridemia – in 13.7%. There was not statistical difference neither between the prevalence of the MetS, nor between the prevalence of its individual components in female and male GD patients. The MetS was significantly more frequent in older patients, as well as abdominal obesity, hyperglycemia and arterial hypertension. There was not statistical difference in the frequency of the MetS and its components between GD patients with
and without GO, except for waist circumference, which was significantly higher in patients with GO. Conclusions: The presence of the MetS and its components among GD patients are to great extent similar to those reported in the general population, which underlines the need for their screening and proper treatment in this subpopulation.
References
Antonelli A, Ferrari SM, Ragusa F, et al. Graves’ disease: Epidemiology, genetic and environmental risk factors and
viruses. Best Pract Res Clin Endocrinol Metab. 2020; 34(1):101-110.
Wémeau J, Klein M, Sadoul JL, et al. Graves’ disease: Introduction, epidemiology, endogenous and environmental pathogenic factors. Ann Endocrinol. 2018;79(6):599-607.
Iddah MA, Macharia BN. Autoimmune thyroid disorders. ISRN Endocrinol. 2013; 2013:509764.
Antonelli A, Fallahi P, Elia G, et al. Graves’ disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab. 2020; 34(1):101388.
Kahaly GJ, Bartalena L, Hegedüs L, et al. 2018 European thyroid association guideline for the management of Graves’hyperthyroidism. Eur Thyroid J. 2018; 7(4):167-186.
Jansson S, Berg’ G, Lindstedt G, et al. Overweight-a common problem among women treated for hyperthyroidism. Postgrad Med J. 1993; 69(808):107-111.
Dale J, Daykin J, Holder R, et al. Weight gain following treatment of hyperthyroidism. Clinical Endocrinology. 2001; 55(2):233-239.
O’malley B, Hickey J, Nevens E, et al. Thyroid dysfunction – weight problems and the psyche: the patients’ perspective. J Hum Nutr Diet. 2008; 13(4):243-248.
Brunova J, Bruna J, Joubert G, et al. Weight gain in patients after therapy for hyperthyroidism. S Afr Med. 2003; 93(7):529-531.
Kyriacou A, Makris KC, Syed AA, et al. Weight gain following treatment of hyperthyroidism – A forgotten tale. Clin Obes. 2019; 9(5):e12328.
Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep. 2003; 5(6):513-520.
Rizos CV, Elisaf MS, Liberopoulos EN. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J. 2011;5:76-84
Potenza M, Via MA, Yanagisawa RT. Excess thyroid hormone and carbohydrate metabolism. Endocr Pract. 2009; 15(3):254-262.
Dobrowolski P, Prejbisz A, Kurylowicz A, et al. Metabolic syndrome a new definition and management guidelines. Arch Med Sci. 2022; 18(5):1133-1156.
Alberti K, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention. 2009; 120(16):1640-1645.
Elabbassi WN, Haddad HA. The global epidemic of metabolic syndrome. Saudi Med J. 2005; 26(3):373-375.
Scuteri A, Laurent S, Cucca F, et al. The metabolic syndrome across Europe – different clusters of risk factors. Metabolic syndrome and Arteries REsearch (MARE). Eur J Prev Cardiol. 2015; 22(4):486-491.
Kuk JL, Ardern CI. Age and sex differences in the clustering of metabolic syndrome factors: Association with mortality risk.
Diabetes Care. 2010; 33(11):2457-2461. 19. Sengupta J, Das H, Chellaiyan D VG, et al. An observational study of incidence of metabolic syndrome among patients with controlled Grave’s disease. Clin Epidemiol Glob Heal. 2022; 15(5):101010.
Krishnamoorthy Y, Rajaa S, Murali S, et alr SS. Prevalence of metabolic syndrome among the adult population in India: A systematic review and meta-analysis. PLoS One. 2020; 15(10):1-25.
Borissova A-M, Shinkov A, Vlahov J, et al. Metabolic syndrome in Bulgarian population in 2012 year. Endocrinologia. 2015; 20(3):144-152.
Borissova A-M, Kovatcheva R, Shinkov A, et al. Prevalence and features of the metabolic syndrome in unselected Bulgarian population. Endocrinologia. 2007; 12(2):68-77.
Borissova A-M, Shinkov A, Vlahov J, et al. Features of metabolic syndrome in Bulgarian population. Endocrinologia. 2015; 20(3):153-162.
Lin X, Xu Y, Pan X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020; 10(1):1-11.
Cowie CC, Casagrande SS, Menke A, et al. Prevalence and Incidence of Type 2 Diabetes and Prediabetes. In: Diabetes in America 3rd ed. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018.
Borissova A-M, Shinkov A, Vlahov J, et al. Prevalence of arterial hypertension in Bulgarian population (actual data). Endocrinologia.
; 20(2):76-81.
Borissova A-M, Shinkov A, Vlahov J, et al. Dyslipidemia – prevalence in Bulgarian population today. Endocrinologia. 2015; 20(3):163-173.
Snijder MB, Zimmet PZ, Visser M, et al. Independent and opposite associations of waist and hip circumferences with diabetes,
hypertension and dyslipidemia: The AusDiab Study. Int J Obes. 2004; 28(3):402-409.
Jaeschke L, Steinbrecher A, Pischon T. Measurement of waist and hip circumference with a body surface scanner: Feasibility, validity, reliability, and correlations with markers of the metabolic syndrome. PLoS One. 2015; 10(3):1-16.
Hu L, Huang X, You C, et al. Prevalence of overweight, obesity, abdominal obesity and obesity-related risk factors in southern China. PLoS One. 2017; 12(9):1-14.
Jura M, Kozak LP. Obesity and related consequences to aging. Age. 2016; 38(1):23-30.
Cooper A, Gupta S, Moustafa A, et al. Sex/Gender Differences in Obesity Prevalence, Comorbidities, and Treatment. Curr Obes Rep. 2021; 10(4):458-466.
Borissova A-M, Shinkov A, Vlahov J, et al. Prevalence of diabetes mellitus and prediabetes in Bulgaria today. Endocrinologia.
; 17(4):182-192.
Kumar DV, Mathur DSL, Tuteja DRK. Effects of Thyroid Dysfunction on Lipid Profile. Int J Med Biomed Stud. 2019; 3(6):76-84.
Zhang L, Evans A, von Ruhland C, et al. Distinctive features of orbital adipose tissue (Oat) in Graves’ orbitopathy. Int J Mol Sci. 2020; 21(23):1-17.
Khanna D, Khanna S, Khanna P, et al. Obesity: A Chronic Low-Grade Inflammation and Its Markers. Cureus. 2022; 14(2): e22711.
Lozanov L. Association between thyroid function and adipose tissue. Endocrinologia. 2015; 20(3):125-138.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 M. Stoynova, L. Lilova, D. Petrova, I. Yankova, I. Dimitrova, A. Shinkov, R. Kovatcheva (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.
Journal Acta Medica Bulgarica 
